Science

Envu Completes Transfer of Global Specialty Solutions Assets in Australia, New Zealand, and Japan

🕔5/5/2025 11:00:00 PM

Envu, a global leader in environmental science solutions, today announced the successful transition of FMC Global Specialty Solutions (GSS) assets into its Australia, New Zealand, and Japan operations, representing a significant step for its growth in the APAC region and a notable expansion of its offerings for customers.

Read Full Article

Final Days to Submit Abstracts for the 2025 Lysosomal Disease Summit in Sydney, Australia

🕔5/4/2025 8:00:00 AM

The 3rd Annual Lysosomal Disease Summit, to be held 24–26 October 2025 at the Hyatt Regency Sydney, invites researchers, clinicians, and industry partners to participate in this premier scientific meeting focused on advancing lysosomal disease research, diagnostics, and care across the Asia-Pacific region.

Read Full Article

Plastic Surgeon to Sculptor: The Art of Life

🕔4/30/2025 4:34:49 PM

Esteemed plastic surgeon and visionary author Dr. Anthony J. Emmett invites readers on a transformative journey with the release of his latest work, Plastic Surgeon to Sculptor: The Art of Life.

Read Full Article

HUD App’s New Anti-Commitment Mode (ACM) Feature Uses AI to Help Casual Daters Stay Emotionally Clear and In Control

🕔4/30/2025 8:28:58 AM

HUD App today announces the launch of Anti-Commitment Mode (ACM), a unique AI-powered feature designed to support users in maintaining emotional clarity and holding boundaries while exploring casual connections.

Read Full Article

Meatable and TruMeat Collaborate to Accelerate Cost-effective Cultivated Meat Production

🕔4/30/2025 4:00:00 AM

Meatable, the leader in cultivated meat technology, and TruMeat, specializing in the contract manufacturing of cultivated meat at commercial scale, have formed a strategic collaboration to advance the global commercialization of cultivated meat.

Read Full Article

Contraline Announces 24-Month Safety and Efficacy Results from First-in-Human Trial of ADAM™

🕔4/24/2025 12:00:00 PM

Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reached a critical milestone, demonstrating both safety and efficacy at the 24-month mark.

Read Full Article

Opterro, Inc. and Polytec GmbH Announce Strategic Distribution Agreement Across Eight European Countries

🕔4/23/2025 9:42:59 PM

Opterro, Inc. (www.opterro.com), a global leader in advanced fiber-optic sensing solutions, is pleased to announce a strategic distribution agreement with Polytec GmbH (www.

Read Full Article